• Publications
  • Influence
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
PURPOSE Expression of Bcl-2 protein is associated with chemotherapy resistance and decreased survival in chronic lymphocytic leukemia (CLL). We evaluated whether oblimersen would improve response toExpand
  • 211
  • 7
The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome.
Kaposi's sarcoma is a multifocal systemic neoplasm histologically characterized by proliferating fibroblastic and microvascular elements. Initial signs include macules, papules, or nodules on theExpand
  • 198
  • 5
Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma.
A case of catheter-associated fungemia caused by Fusarium chlamydosporum is described in a patient with lymphocytic lymphoma. The fungus, which has been isolated from soil but not reported to causeExpand
  • 76
  • 5
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.
PURPOSE A randomized trial of oblimersen plus fludarabine/cyclophosphamide (OBL-FC; n = 120) versus FC (n = 121) was conducted in patients with relapsed/refractory chronic lymphocytic leukemia (CLL).Expand
  • 145
  • 5
Cytogenetic and histologic correlations in malignant lymphoma.
Although a number of studies have indicated correlations between histologic subtypes of tumors and certain nonrandom chromosome changes, cytogenetic studies of lymphoma are in an early stage comparedExpand
  • 140
  • 4
Acute lymphoblastic leukemia in adults.
  • 170
  • 3
Cytofluorometric detection of chronic myelocytic leukemia supervening in a patient with chronic lymphocytic leukemia.
An 82-year-old woman with stage I chronic lymphocytic leukemia presented with systemic symptoms, minimal adenopathy, hepatosplenomegaly, and anemia five years after the initial diagnosis was made andExpand
  • 16
  • 3
Autologous bone marrow transplantation for patients with poor-prognosis lymphoma.
Review of prognostic factors at Memorial Hospital in New York City has shown that adult patients with large-cell lymphoma (diffuse histiocytic lymphoma by Rappaport classification) who have highExpand
  • 191
  • 2
Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols.
Two successive protocols (L-10 and L-10M) employing multidrug induction therapy with vincristine, prednisone, and doxorubicin (Adriamycin) plus an intensive consolidation phase and maintenanceExpand
  • 146
  • 2
Establishment of a near-tetraploid B-cell lymphoma line with duplication of the 8;14 translocation.
The neoplastic cells of a patient with diffuse histiocytic lymphoma were grown in three systems: Soft agar, liquid culture, and by heterotransplantation into the nude mouse. In each case, the growingExpand
  • 27
  • 2